All Stories

  1. Interaction of Dasabuvir With Clopidogrel: Did Predictions by Physiologically Based Pharmacokinetics Modeling Pass the Test?

    Article • Clinical Pharmacology & Therapeutics, September 2018, Wiley

    Mohamad Shebley

  2. Physiologically Based Pharmacokinetic Model Qualification and Reporting Procedures for Regulatory Submissions: A Consortium Perspective

    Article • Clinical Pharmacology & Therapeutics, February 2018, Wiley

    Mohamad Shebley, Shinji Yamazaki

  3. Physiologically Based Pharmacokinetic Modeling Suggests Limited Drug-Drug Interaction Between Clopidogrel and Dasabuvir

    Article • Clinical Pharmacology & Therapeutics, June 2017, Wiley

    Mohamad Shebley

  4. Mechanisms and Predictions of Drug-Drug Interactions of the Hepatitis C Virus Three Direct-Acting Antiviral Regimen: Paritaprevir/Ritonavir, Ombitasvir, and Dasabuvir

    Article • Drug Metabolism and Disposition, May 2017, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Mohamad Shebley

  5. Response to “Quantitative Prediction of Drug-Drug Interactions Involving Inhibitory Metabolites by Physiologically Based Pharmacokinetic Models: Is It Worth?”

    Article • CPT Pharmacometrics & Systems Pharmacology, April 2017, Wiley

    Mohamad Shebley